Survey: Provider attitudes to, and interest in, long-acting formulations of TB treatment

Healthcare providers and policymakers in low- and middle-income countries (LMICs) are invited to take part in an online survey to help the Unitaid-funded LONGEVITY Project understand attitudes about long-acting TB preventive treatment. There are currently several long-acting formulations under development for TB prevention. The survey responses will help ensure that long-acting technologies better serve people who need them.

The survey can be accessed here. It is available in English and French.